Very early researchStudy completedNCT03204266What this trial is testingOral Supplementation to Enhance Recovery Pilot StudyWho this might be right forMalignant Neoplasms of Urinary Tract M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Looking for participantsNCT06265025What this trial is testingGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsWho this might be right forHead and Neck CancerMalignant MelanomaColorectal Cancer+3 more GeneMedicine Co., Ltd. 125
Large-scale testing (Phase 3)Ended earlyNCT04588246What this trial is testingComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more NRG Oncology 19
Early research (Phase 1)Looking for participantsNCT06332755What this trial is testingStudy to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLCWho this might be right forNon-small Cell Lung Cancer(NSCLC)Head and Neck Squamous Cell Carcinoma(HNSCC)Renal Cell Carcinoma(RCC)+2 more LG Chem 76
Testing effectiveness (Phase 2)Active Not RecruitingNCT03284385What this trial is testingTesting AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2Who this might be right forClear Cell Renal Cell CarcinomaLocally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Malignant Solid Neoplasm+4 more National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT03752398What this trial is testingXmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)Who this might be right forMelanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more Xencor, Inc. 198
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more National Cancer Institute (NCI) 6,452
Not applicableLooking for participantsNCT00026884What this trial is testingCollection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant DiseaseWho this might be right forMalignant NeoplasmsHereditary Neoplastic SyndromesKidney Cancer+2 more National Cancer Institute (NCI) 5,950
Not applicableLooking for participantsNCT02402244What this trial is testingProject: Every Child for Younger Patients With CancerWho this might be right forAdrenal Gland PheochromocytomaCarcinoma In SituCentral Nervous System Neoplasm+15 more Children's Oncology Group 75,000
Early research (Phase 1)Active Not RecruitingNCT03872947What this trial is testingTRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsWho this might be right forSolid TumorColorectal CancerCholangiocarcinoma+9 more Toray Industries, Inc 138
Early research (Phase 1)Study completedNCT00441337What this trial is testingMDX-1106 in Patients With Selected Refractory or Relapsed MalignanciesWho this might be right forCarcinoma, Non-Small-Cell LungColorectal CancerMalignant Melanoma+2 more Bristol-Myers Squibb 39
Not applicableStudy completedNCT00079222What this trial is testingVoriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forCancer Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Early research (Phase 1)Looking for participantsNCT07244835What this trial is testingDEG6498 in Participants With Solid TumorsWho this might be right forMalignant Neoplasms Degron Therapeutics Co. 100
Large-scale testing (Phase 3)Study completedNCT00002641What this trial is testingSurgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaWho this might be right forEndometrial CancerKidney CancerOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 350
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Ended earlyNCT05714553What this trial is testingNUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursWho this might be right forAdvanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more NuCana plc 19
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Not applicableLooking for participantsNCT04981119What this trial is testingSolid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingWho this might be right forSolid Tumor, AdultColorectal CancerNon Small Cell Lung Cancer+14 more A2 Biotherapeutics Inc. 500
Testing effectiveness (Phase 2)UnknownNCT00036712What this trial is testingLight-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+9 more Medical College of Wisconsin 80